These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32501985)

  • 1. Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention.
    Wang H; Feng M
    Medicine (Baltimore); 2020 Jun; 99(23):e20402. PubMed ID: 32501985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention.
    Ghonim AA; Mostafa A; Emara A; Algazzar AS; Qutub MA
    Cardiovasc J Afr; 2019 Sep/Oct 23; 30(5):285-289. PubMed ID: 31194213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.
    Chen GX; Wang HN; Zou JL; Yuan XX
    World J Emerg Med; 2020; 11(3):157-163. PubMed ID: 32351648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
    Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
    Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical outcomes and safety of primary percutaneous coronary intervention combined with tirofiban therapy in patients with acute ST-segment elevation myocardial infarction].
    Shen J; Zhang Q; Zhang RY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1005-9. PubMed ID: 18269820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction.
    Zhao YJ; Fu XH; Ma XX; Wang DY; Dong QL; Wang YB; Li W; Xing K; Gu XS; Jiang YF
    Exp Ther Med; 2013 Aug; 6(2):479-484. PubMed ID: 24137212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of recombinant human pro-urokinase and tirofiban on myocardial blood flow perfusion in ST elevation myocardial infarction patients receiving primary percutaneous coronary intervention: A one-center retrospective observational study.
    Yao Z; Li W; Cheng L; Cao M; Pang Z; Li Y
    Medicine (Baltimore); 2019 Jul; 98(27):e16143. PubMed ID: 31277114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between culprit vessel/tirofiban and reperfusion bradyarrhythmia in patients with ST-segment elevation myocardial infarction after emergency PCI.
    Ma Z; Ning B; Wu D; Liu WG; Guo YJ
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5137-5144. PubMed ID: 34486688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction].
    Tong ZC; Li Q; Chen M; Miao GB; Wei Y; Li FO; Zhao H; Zhang JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):839-44. PubMed ID: 24377889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
    Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.
    Zhang J; Ding G
    Evid Based Complement Alternat Med; 2021; 2021():8371996. PubMed ID: 34221091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Hu S; Wang H; Zhu J; Li M; Li H; Gao D; Zhang H
    Medicine (Baltimore); 2018 May; 97(21):e10850. PubMed ID: 29794782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect and safety of tirofiban on acute ST segment elevation myocardial infarction patients receiving no early reperfusion therapy].
    Zhang DP; Wang LF; Wang HS; Xu L; Li WM; Ni ZH; Xia K; Liu Y; Yang XC
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):273-7. PubMed ID: 27030614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of standard-dose versus half-dose tirofiban in patients with non-ST elevation acute coronary syndromes undergoing early percutaneous coronary intervention.
    Li W; Fu X; Xue H; Wang Y; Wang X; Zhao Y; Geng W; Yang Z; Gu X; Hao G; Jiang Y; Fan W; Wu W; Li S
    Cardiovasc Ther; 2013 Aug; 31(4):210-4. PubMed ID: 22954393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty.
    Bilsel T; Akbulut T; Yesilcimen K; Terzi S; Sayar N; Dayi SU; Akgoz H; Ergelen M; Ciloglu F
    Heart Vessels; 2006 Mar; 21(2):102-7. PubMed ID: 16550311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of tirofiban on acute non-ST segment elevation myocardial infarction patients not receiving early reperfusion intervention].
    Zhang D; Wang L; Wang H; Xu L; Li W; Ni Z; Xia K; Liu Y; Yang X;
    Zhonghua Nei Ke Za Zhi; 2014 Mar; 53(3):193-7. PubMed ID: 24767206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.
    Song YB; Hahn JY; Gwon HC; Kim JH; Lee SY; Choe YH; Choi SH; Choi JH; Lee SH
    Clin Cardiol; 2009 Jun; 32(6):321-6. PubMed ID: 19569068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.